6Vauth R,Kleim B,Wirtz M, et ah Self-eficacy and empowerment as outcomes of self-stigmatizing and coping in schizophrenia [ J ]. Psychially Res, 2007,150:71-80.
4Braniecka A, Trzebifiska E, Dowgiert A, et al. Mixed emotions and coping: the benefits of secondary emotions [ J ]. PLoS One, 2014, 9(8) :e103940.
5Hechtman LA, Raila H, Chiao JY, et al. Positive Emotion Regula- tion and Psychopathology: A Transdiaguostic Cultural Neuroscience Approach[J]. J Exp Psychopathol, 2013, 4(5) :502 -528.
6Hough D, Gopal S, Vijapurkar U, et al. Paliperidone palmitate maintenance treatment in delaying the time - to - relapse in patients with schizophrenia: a randomized, double - blind, placebo - con- trolled study[J]. Schizophr Res, 2010, 116 (2 -3) :107 - 117.
7Sapra M, Vahia IV, Reyes PN, et al. Subjective reasons for adher- ence to psychotropic medication and associated factors among older adults with schizophrenia[J]. Schizophr Res, 2008,106 (2 -3) : 348 - 355.
8Andreasen NC,Olsen S.Negative v positive schizophrenia:Definition and validation.Arch Gen Psychiatry,1982;39(7):789-794.
9Ventura J,Subotnik KL,Gitlin MJ,et al.Negative symptoms and functioning during the first year after a recent onset of schizophrenia and 8 years later.Schizophr Res.2015;161(2-3):407-413.
